Back to Archived Journals » Patient Intelligence » Volume 4

Patient considerations in the management of mental stress in psoriasis

Authors Schmid-Ott, Boehm, Stock-Gissendanner S

Received 1 February 2012

Accepted for publication 30 March 2012

Published 14 June 2012 Volume 2012:4 Pages 41—50

DOI https://doi.org/10.2147/PI.S18793

Review by Single anonymous peer review

Peer reviewer comments 2



Gerhard Schmid-Ott,1,2 Dana Böhm,1,3 Scott Stock Gissendanner1,2

1Hospital Management and Stress Medicine, IREHA Institute for Innovative Rehabilitation, Loehne, Germany; 2Berolina Klinik, Loehne, Germany; 3Saale Reha-Klinikum, Bad Koesen, Germany

Abstract: Psoriasis is an incurable, inflammatory disease of the skin with a complex etiology. The disease has serious negative repercussions for patients' quality of life, but quality of life does not depend on physical symptoms alone. The impact of somatic symptoms on life quality is mitigated by various forms of mental stress. Through a discussion of the physical and mental burdens of psoriasis, the psychosocial determinants of life quality, common treatment options, and issues of adherence and resilience, this paper seeks to identify common sources of mental stress and appropriate strategies for stress management for psoriasis patients. The paper argues that a sustained and successful management of psoriasis depends on patients playing an active role in the prevention and reduction of their own personal sources of mental stress. Health-care professionals can and should assist patients in doing so.

Keywords: psoriasis, shared decision-making, treatment, adherence, resilience

Creative Commons License © 2012 The Author(s). This work is published and licensed by Dove Medical Press Limited. The full terms of this license are available at https://www.dovepress.com/terms.php and incorporate the Creative Commons Attribution - Non Commercial (unported, v3.0) License. By accessing the work you hereby accept the Terms. Non-commercial uses of the work are permitted without any further permission from Dove Medical Press Limited, provided the work is properly attributed. For permission for commercial use of this work, please see paragraphs 4.2 and 5 of our Terms.